NCT00004045View on ClinicalTrials.gov

Chemotherapy in Treating Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 1999

Primary Completion Date

August 31, 2001

Study Completion Date

August 31, 2001

Conditions

Prostate Cancer

Interventions

DRUG

exatecan mesylate

Trial Locations (2)

77060

U.S. Oncology Research Inc., Houston

78245-3217

Institute for Drug Development, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY